Colgate-Palmolive Company (CL) Shares Bought by Exencial Wealth Advisors LLC
Exencial Wealth Advisors LLC increased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 5.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 53,861 shares of the company’s stock after buying an additional 2,941 shares during the period. Colgate-Palmolive Company comprises about 1.5% of Exencial Wealth Advisors LLC’s investment portfolio, making the stock its 18th largest position. Exencial Wealth Advisors LLC’s holdings in Colgate-Palmolive Company were worth $3,525,000 as of its most recent filing with the SEC.
Several other hedge funds also recently modified their holdings of CL. WMS Partners LLC raised its stake in Colgate-Palmolive Company by 7.0% in the second quarter. WMS Partners LLC now owns 7,278 shares of the company’s stock worth $533,000 after buying an additional 474 shares during the period. Fundsmith LLP raised its stake in Colgate-Palmolive Company by 7.0% in the second quarter. Fundsmith LLP now owns 1,384,087 shares of the company’s stock worth $100,785,000 after buying an additional 90,358 shares during the period. First Personal Financial Services raised its stake in Colgate-Palmolive Company by 9.5% in the third quarter. First Personal Financial Services now owns 31,587 shares of the company’s stock worth $2,342,000 after buying an additional 2,745 shares during the period. Toronto Dominion Bank raised its stake in Colgate-Palmolive Company by 33.7% in the third quarter. Toronto Dominion Bank now owns 82,251 shares of the company’s stock worth $6,106,000 after buying an additional 20,733 shares during the period. Finally, BB&T Corp raised its stake in Colgate-Palmolive Company by 613.2% in the second quarter. BB&T Corp now owns 306,125 shares of the company’s stock worth $22,409,000 after buying an additional 263,205 shares during the period. 73.24% of the stock is owned by hedge funds and other institutional investors.
Colgate-Palmolive Company (NYSE:CL) opened at 69.00 on Friday. Colgate-Palmolive Company has a one year low of $63.43 and a one year high of $75.38. The firm has a 50-day moving average of $66.61 and a 200-day moving average of $69.81. The company has a market capitalization of $61.25 billion, a P/E ratio of 25.37 and a beta of 0.70.
Colgate-Palmolive Company (NYSE:CL) last issued its quarterly earnings data on Friday, January 27th. The company reported $0.75 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.75. The firm earned $3.72 billion during the quarter, compared to the consensus estimate of $3.87 billion. Colgate-Palmolive Company had a return on equity of 4,897.09% and a net margin of 16.06%. The company’s quarterly revenue was down 4.6% on a year-over-year basis. During the same period last year, the company earned $0.73 EPS. On average, analysts anticipate that Colgate-Palmolive Company will post $2.91 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 15th. Investors of record on Monday, January 23rd were given a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 2.26%. The ex-dividend date was Thursday, January 19th. Colgate-Palmolive Company’s payout ratio is 57.35%.
“Colgate-Palmolive Company (CL) Shares Bought by Exencial Wealth Advisors LLC” was originally published by Daily Political and is owned by of Daily Political. If you are viewing this report on another publication, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this report can be accessed at http://www.dailypolitical.com/2017/02/17/colgate-palmolive-company-cl-shares-bought-by-exencial-wealth-advisors-llc.html.
A number of analysts recently weighed in on CL shares. Berenberg Bank started coverage on shares of Colgate-Palmolive Company in a research note on Wednesday, January 25th. They issued a “hold” rating and a $68.00 price objective for the company. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Colgate-Palmolive Company in a research note on Tuesday, November 15th. Stifel Nicolaus lowered their price objective on shares of Colgate-Palmolive Company from $75.00 to $70.00 and set a “hold” rating for the company in a research note on Monday, January 30th. Zacks Investment Research lowered shares of Colgate-Palmolive Company from a “hold” rating to a “sell” rating in a research note on Tuesday, December 27th. Finally, Barclays PLC reaffirmed a “hold” rating and issued a $63.00 price objective on shares of Colgate-Palmolive Company in a research note on Tuesday, January 10th. One research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and two have issued a buy rating to the stock. Colgate-Palmolive Company presently has a consensus rating of “Hold” and a consensus price target of $73.42.
In related news, insider Jennifer Daniels sold 868 shares of the firm’s stock in a transaction dated Monday, January 9th. The stock was sold at an average price of $66.62, for a total transaction of $57,826.16. Following the completion of the sale, the insider now directly owns 36,813 shares of the company’s stock, valued at approximately $2,452,482.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stephen I. Sadove sold 8,000 shares of the firm’s stock in a transaction dated Friday, February 3rd. The stock was sold at an average price of $66.00, for a total value of $528,000.00. Following the sale, the director now directly owns 33,761 shares of the company’s stock, valued at $2,228,226. The disclosure for this sale can be found here. Insiders have sold a total of 23,607 shares of company stock valued at $1,562,774 over the last three months. Corporate insiders own 1.05% of the company’s stock.
About Colgate-Palmolive Company
Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.